Elsa

What Elsa does

Elsa Science AB, founded in 2017 and headquartered in Stockholm, Sweden, operates a digital health platform built around the CE-marked Elsa Science mobile application, a class I medical device registered with the Swedish Medical Products Agency under the EU Medical Device Regulation. The app targets individuals living with chronic rheumatic conditions — primarily rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Still's disease — and provides symptom tracking, medication logging, lifestyle-habit correlation, science-based educational programs grounded in cognitive behavioral therapy, and data-sharing features for clinical consultations. The platform is co-developed with patients, rheumatologists, and academic researchers from Karolinska Institutet, Uppsala University, Linköping University, LUMC, and FAU, and is integrated with Apple HealthKit, Google Fit, and Health Connect to ingest wearable activity data.

Elsa has extended its product surface with two adjacent modules: Elsa Rheumatic?, a symptom-screening tool intended to drive early care-seeking, and Elsa Remote Patient Monitoring, a provider-facing module that allows rheumatology teams to track treatment progress in real time and operationalize the treat-to-target clinical approach. The company is structured as a four-sided platform intended to connect patients, healthcare providers, academic researchers, and life science industry partners around shared health data.

Commercially, the consumer app is offered free of charge with no in-app purchases, and the stated revenue model rests on three streams: managed-services partnerships with healthcare providers (anchored by the RPM module), data-monetization and research collaborations with pharmaceutical and diagnostic companies, and credibility-driven partnerships with patient organizations such as the Swedish Rheumatism Association and Unga Reumatiker. Distribution is mobile-first via the iOS App Store and Google Play (5,000+ reported downloads) plus direct field engagement for enterprise healthcare deals. Following a 38.7M SEK (~$4.4M) round in November 2021 led by HealthCap, Elsa initiated a clinical study in Wisconsin as its entry point into the US market, deliberately bypassing the slower Swedish reimbursement pathway. Total disclosed funding since inception is approximately $7.95M across five rounds from 2018 through 2021.

Name

Elsa

Legal name

Elsa Science AB

Website

https://elsa.science

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Elsa Science AB operates a CE-marked mobile health platform for patients with chronic rheumatic diseases, offering symptom tracking, medication logging, and science-based self-care programs, with provider-facing remote patient monitoring and research data partnerships with pharma.

Ownership category

akta.pro rank

Product category

Digital Health Patient Self-Management

NAICS

Software Publishers (513210), Home Health Care Services (62161)

SIC

Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF)

akta.pro secondary industries

Patient Education, Content & Personalized Journey Orchestration (HLACAEAE), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)

Keywords

• Rheumatic disease app
• Patient self-management
• Remote patient monitoring
• Symptom tracking software
• Digital therapeutics

Headquarters

HQ city

Stockholm

HQ country

Sweden

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Free Consumer App: The Elsa app is currently completely free with no in-app purchases or hidden costs. Revenue model appears to be focused on growth and data collection for research partnerships rather than direct consumer monetization.
2. Healthcare Provider Partnerships: Elsa Remote Patient Monitoring enables partnerships with healthcare providers and systems for remote monitoring services
3. Research Collaborations: Partnerships with pharmaceutical companies and diagnostic companies through data sharing and research collaborations

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels9 records

Core offering

Elsa Science operates a CE-marked mobile health platform built around the Elsa Science App, which lets patients with rheumatic conditions (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Still's disease) log symptoms, medications, and lifestyle habits and share insights with their healthcare providers. The platform is supplemented by the Elsa Rheumatic? symptom-screening tool for early-stage detection and Elsa Remote Patient Monitoring, which gives clinicians a real-time view of patient treatment progress to support treat-to-target decisions. The app is offered free to consumers while monetization flows from healthcare-provider partnerships and research collaborations with life-science companies.

Product overview

Elsa Science is a digital health platform built around the Elsa Science App as its core product, supplemented by Elsa Rheumatic? (a symptom screening tool for early-stage rheumatic disease detection) and Elsa Remote Patient Monitoring (a healthcare-provider-facing remote monitoring feature). The platform is designed to support individuals living with chronic rheumatic diseases — primarily rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and Still's disease — by providing symptom tracking, medication logging, lifestyle habit analysis, science-based educational programs, and data-sharing capabilities with healthcare providers. The platform is CE-marked as a medical device and registered with the Swedish Medical Products Agency.

Differentiator

Problem solved

Functional benefit

Brands

• Elsa Rheumatic?: A symptom checking tool developed with patients, healthcare providers and UX designers to support and encourage people to seek treatment at an early stage of disease onset.
• Elsa Remote Patient Monitoring

Products and services

• Elsa Science App A CE-marked iOS and Android mobile application for patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Still's disease that enables symptom, medication, and lifestyle tracking, science-based educational programs, personalized plans, and data sharing with healthcare providers.
• Elsa Rheumatic? Screening Tool A symptom-checking tool developed with rheumatologists and patients that helps individuals prepare for a doctor visit when a rheumatic condition is suspected and supports early-stage detection.
• Elsa Remote Patient Monitoring A provider-facing digital tool that enables rheumatologists and healthcare teams to monitor patient treatment progress in real time and supports treat-to-target treatment decisions based on patient-reported data.

Quantifiable outcome

• Patients with chronic conditions spend 8,765 hours per year on self-care vs. only 1 hour with healthcare providers
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature8 records

Partnerships

13 partnerships are on record, tiered core and minor.

• Karolinska InstitutetcoreStrategic or Co-development PartnerResearch collaboration with co-founders Lars Klareskog (Professor of Rheumatology) and Lars Alfredsson (Professor of Epidemiology) from Karolinska Institutet.
• Uppsala UniversitycoreStrategic or Co-development PartnerAcademic research partnership for scientific collaboration on rheumatic disease research.
• Linköping UniversitycoreStrategic or Co-development PartnerAcademic research partnership contributing to the scientific foundation of Elsa's programs.
• Leiden University (LUMC)coreStrategic or Co-development PartnerInternational research collaboration with university in the Netherlands for rheumatic disease research.
• FAU (Friedrich-Alexander-Universität Erlangen-Nürnberg)minorStrategic or Co-development PartnerInternational academic partner shown in collaborator logos on the website.
• ReumaNLminorStrategic or Co-development PartnerDutch rheumatology patient organization partnership shown in collaborator logos.
• WestMidlandsminorStrategic or Co-development PartnerUK healthcare region partnership shown in collaborator logos on rheumatic screening tool.
• Amazon Web ServicescoreTechnology or IntegrationCloud infrastructure provider for hosting production servers. Data processing agreements conform with GDPR requirements.
• Patient Advisory BoardscoreStrategic or Co-development PartnerIncludes Hanna Svensson, Jenny Christensson, Kerstin Grentzelius, Mats Griph, Monica Persson. Provides patient perspective in product development.
• Swedish Rheumatism AssociationcoreStrategic or Co-development PartnerPatient organization partnership for community reach and credibility. Chairman Lotta Håkansson endorses the app.
• Unga ReumatikercoreStrategic or Co-development PartnerYouth rheumatic patient organization. Chairman Cajsa Helin Hollstrand endorses the app and participates in co-development.
• Pharmaceutical CompaniescoreStrategic or Co-development PartnerCollaborations with pharmaceutical companies for research projects and potential future monetization through healthcare partnerships.
• Diagnostic CompaniesminorStrategic or Co-development PartnerCollaborations with diagnostic companies for research projects and ecosystem development.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• RheumaBuddy: Mobile-first app for rheumatology patients to track symptoms, medication, and wellbeing. Directly comparable to Elsa's core patient self-management app, including similar patient-community features and tracking tools.
• ArthritisPower (CreakyJoints / Global Healthy Living Foundation): Patient-facing research registry and app for arthritis patients developed with rheumatologists. Comparable to Elsa in combining symptom tracking with research-grade data collection for life science partners.
• Medisafe: Medication adherence and digital therapeutic platform for chronic disease patients with reminders, tracking, and provider sharing. Overlaps directly with Elsa's Medication Log, reminders, and provider data-sharing capabilities.

Broad incumbents

• Hinge Health: Larger digital MSK care platform offering virtual PT, coaching, and wearable-guided exercise programs that overlap with Elsa's chronic pain and rheumatology patient base, but at much broader scale and with enterprise payer contracts.
• Omada Health: Established virtual chronic-care platform addressing diabetes, hypertension, and musculoskeletal conditions via coaching and RPM. Comparable to Elsa in remote-monitoring-as-care-model for chronic disease, but at significantly larger scale with payer contracts.
• WellDoc (BlueLoop): FDA-cleared digital therapeutic and chronic care RPM platform for diabetes and other conditions. Comparable to Elsa as a regulated (CE-marked/FDA-cleared) software-as-medical-device for chronic disease management with provider integration.

Emerging players

• Kaia Health: Digital therapeutic for MSK pain and chronic conditions combining app-based self-management with coaching. Comparable to Elsa's CBT-based self-care programs and RPM-like remote monitoring features.
• Ada Health: AI-driven symptom assessment and triage platform with a free consumer app. Comparable to Elsa's 'Rheumatic?' screening sub-product as a digital tool that supports early care-seeking and patient navigation.

Regional players

• DigiMe: Consumer health data wallet and integrations for chronic-condition patients, similar in concept to how Elsa centralizes Apple HealthKit/Google Fit/Health Connect data for rheumatic patients.

Others

• CareCentrix (formerly MedSolutions): US-based care coordination and post-acute/home health platform. Comparable only as a payer-facing channel for chronic care RPM — relevant to Elsa's US market entry through Wisconsin but not a direct product competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ElsaScience
• Facebookfacebook.com/ElsaScience.International
• LinkedInlinkedin.com/company/elsascience
• Instagraminstagram.com/elsascience.international

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elsa